Get started
Author

Ida Franiak Pietryga

Observed names: Franiak-Pietryga, Ida, I. Franiak-Pietryga, Ida Franiak-Pietryga, Ida Franiak-pietryga, Ida Franiak‐Pietryga, Ida Franiak–Pietryga
Observed institutions: University of California, Irvine, UC San Diego Health System, University of Łódź, University of California San Diego, Copernicus Memorial Hospital, Medical University of Lodz, Moores Cancer Center
ORCID: 0000-0002-1997-8637
Observed ORCID: 0000-0002-1997-8637
OpenAlex ID: A5046795255
B Cells Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Activated by Radiation and PD-1 Blockade
2020 · Sangwoo S. Kim, Sarek Shen, et al. · Clinical Cancer Research · 201
Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC
2022 · Robert Saddawi-Konefka, Aoife O’Farrell, et al. · Nature Communications · 190
PDF
All That Glitters Is Not Silver—A New Look at Microbiological and Medical Applications of Silver Nanoparticles
2021 · Paweł Kowalczyk, Mateusz Szymczak, et al. · International Journal of Molecular Sciences · 75
PDF
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy
2022 · Dina V. Hingorani, Michael M. Allevato, et al. · Nature Communications · 69
PDF
The Influence of Maltotriose-Modified Poly(propylene imine) Dendrimers on the Chronic Lymphocytic Leukemia Cells in Vitro: Dense Shell G4 PPI
2013 · Ida Franiak-Pietryga, Ewelina Ziółkowska, et al. · Molecular Pharmaceutics · 35
Dendrimers as Drug Nanocarriers: The Future of Gene Therapy and Targeted Therapies in Cancer
2018 · Ida Franiak-Pietryga, Barbara Ziemba, et al. · InTech eBooks · 34
PDF
Activated B Cells and Plasma Cells Are Resistant to Radiation Therapy
2021 · Ida Franiak-Pietryga, Sayuri Miyauchi, et al. · International Journal of Radiation Oncology*Biology*Physics · 29
Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: Considering their contrary potential as biocompatible entity and drug molecule in cancer
2013 · Barbara Ziemba, Ida Franiak-Pietryga, et al. · International Journal of Pharmaceutics · 28
Dendrimer-based nanoparticles for potential personalized therapy in chronic lymphocytic leukemia: Targeting the BCR-signaling pathway
2016 · Ida Franiak-Pietryga, Henryk Maciejewski, et al. · International Journal of Biological Macromolecules · 23
The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy
2025 · Robert Saddawi-Konefka, Riyam Al Msari, et al. · Nature Communications · 20
PDF
Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL
2020 · Ida Franiak-Pietryga, Barbara Ziemba, et al. · Toxicology and Applied Pharmacology · 19
Anti-inflammatory and hypolipemic effects in vitro of simvastatin comparing to epicatechin in patients with type-2 hypercholesterolemia
2008 · I. Franiak-Pietryga, M. Koter-Michalak, et al. · Food and Chemical Toxicology · 19
Neurotoxicity of poly(propylene imine) glycodendrimers
2020 · Ida Franiak-Pietryga, Barbara Ziemba, et al. · Drug and Chemical Toxicology · 18
PDF
PPI‐G4 Glycodendrimers Upregulate TRAIL‐Induced Apoptosis in Chronic Lymphocytic Leukemia Cells
2016 · Ida Franiak‐Pietryga, Kinga Ostrowska, et al. · Macromolecular Bioscience · 18
PDF
Blockage of Wnt/β‐Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro—Preliminary Study
2017 · Ida Franiak‐Pietryga, Henryk Maciejewski, et al. · Macromolecular Bioscience · 14
Affecting NF-κB cell signaling pathway in chronic lymphocytic leukemia by dendrimers-based nanoparticles
2018 · Ida Franiak-Pietryga, Kinga Ostrowska, et al. · Toxicology and Applied Pharmacology · 12
PDF
Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays
2017 · Ida Franiak-Pietryga, Ewelina Ziółkowska, et al. · Anti-Cancer Agents in Medicinal Chemistry · 9
Anti-Tumour Activity of Glycodendrimer Nanoparticles in a Subcutaneous MEC-1 Xenograft Model of Human Chronic Lymphocytic Leukemia
2019 · Barbara Ziemba, Hanna Sikorska, et al. · Anti-Cancer Agents in Medicinal Chemistry · 7
Toward personalized therapy for chronic lymphocytic leukemia
2013 · Małgorzata Rogalińska, Ida Franiak-Pietryga, et al. · Cancer Biology & Therapy · 7
PDF
Type of serum influences the rituximab dependent cytotoxicity and apoptosis of chronic lymphocytic leukemia cells in vitro
2012 · Ewelina Ziółkowska, Ida Franiak-Pietryga, et al. · Postępy Higieny i Medycyny Doświadczalnej · 6
Nanoparticles – a Novel Approach to Chronic Lymphocytic Leukemia Treatment?
2012 · Ida Franiak-Pietryga, Ewelina Ziolkowska, et al. · Blood · 5
There and back again: a dendrimer’s tale
2021 · Barbara Ziemba, Maciej Borowiec, et al. · Drug and Chemical Toxicology · 3
Polymorphisms of Mir-34b/c, Mir-146a and Mir-196a-2 and Predisposition to Chronic Lymphocytic Leukemia and Monoclonal B-Cell Lymphocytosis
2011 · Krzysztof Jamroziak, Janusz Szemraj, et al. · Blood · 3
601 Sequencing immunotherapy before lymphatic ablation unleashes cDC1-dependent antitumor immunity in HNSCC
2021 · Robert Saddawi-Konefka, Aoife O’Farrell, et al. · Regular and Young Investigator Award Abstracts · 2
PDF
The effect of atorvastatin on the erythrocyte plasma membrane and C-reactive protein in menopausal women with metabolic syndrome
2009 · Ida Franiak-Pietryga, Magdalena Balcerak, et al. · Menopause Review/Przegląd Menopauzalny · 2
Works count: 47
Citation count: 851
H-index: 14
I10-index: 16
Year
Topic
Type